Pituitary adenylate cyclase-activating polypeptide (PACAP)-deficient mice display remarkable behavioral changes including increased novelty-seeking behavior and reduced hypothermia induced by either serotonin (5-HT)(1A) receptor agonists or ethanol. Because 5-HT(1A) receptors have been implicated in the development of alcohol dependence, we have examined ethanol preference in PACAP-deficient mice using a two-bottle choice and a conditioned place preference test, as well as additive effects of ethanol and 5-HT(1A) receptor agents on hypothermia. PACAP-deficient mice showed an increased preference towards ethanol compared with wild-type mice. However, they showed no preference for the ethanol compartment after conditioning and neither preference nor aversion to sucrose or quinine. The 5-HT(1A) receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) restored the attenuated hypothermic response to ethanol in the mutants to similar levels in wild-type mice, with no effect in wild-types. In contrast, the 5-HT(1A) receptor antagonist WAY-100635 attenuated the ethanol-induced hypothermia in wild-type mice, with no effect in the mutants. These results demonstrate increased ethanol preference in PACAP-deficient mice that may be mediated by 5-HT(1A) receptor-dependent attenuation of ethanol-induced central inhibition.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bbrc.2009.11.136 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effects of PACAP Deficiency on Immune Dysfunction and Peyer's Patch Integrity in Adult Mice.
Int J Mol Sci
October 2024
Department of Medical Microbiology and Immunology, Medical School, University of Pecs, 7624 Pecs, Hungary.
Article Synopsis
- PACAP is a neuropeptide known for its protective and anti-inflammatory effects, influencing both innate and adaptive immune responses, but there's limited research on its role in gut-associated lymphoid tissue.
- The study examined Peyer's patches in two groups of mice (wild-type and PACAP-deficient) at different ages, focusing on immune cell populations and checkpoint molecule expression.
- Findings revealed that aging affected T cell populations and checkpoint molecules in WT mice while PACAP KO mice showed altered immune responses, indicating that PACAP is critical for maintaining intestinal immune balance and may have implications for conditions like inflammatory bowel disease.
Pituitary adenylate cyclase-activating polypeptide deficient mice show length abnormalities of the axon initial segment.
J Pharmacol Sci
November 2023
Department of Pharmacology, Graduate School of Dentistry, Osaka University, 1-8 Yamadaoka, Suita, Osaka 565-0871, Japan; Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan. Electronic address:
We previously found that pituitary adenylate cyclase-activating polypeptide (PACAP)-deficient (PACAP) mice exhibit dendritic spine morphology impairment and neurodevelopmental disorder (NDD)-like behaviors such as hyperactivity, increased novelty-seeking behavior, and deficient pre-pulse inhibition. Recent studies have indicated that rodent models of NDDs (e.g.
View Article and Find Full Text PDFThe Protective Effects of Endogenous PACAP in Oxygen-Induced Retinopathy.
J Mol Neurosci
December 2021
Department of Anatomy, MTA-PTE PACAP Research Team, Medical School, University of Pecs, Pecs, Hungary.
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide having trophic and protective functions in neural tissues, including the retina. Previously, we have shown that intravitreal PACAP administration can maintain retinal structure in the animal model of retinopathy of prematurity (ROP). The purpose of this study is to examine the development of ROP in PACAP-deficient and wild-type mice to reveal the function of endogenous PACAP.
View Article and Find Full Text PDFMelanotan II, a melanocortin agonist, partially rescues the impaired thermogenic capacity of pituitary adenylate cyclase-activating polypeptide deficient mice.
Exp Physiol
February 2021
Northern Medical Program, University of Northern British Columbia, Prince George, British Columbia, Canada.
New Findings: What is the central question of this study? Can chronic treatment of pituitary adenylate cyclase-activating polypeptide (PACAP) deficient mice with the melanocortin agonist melanotan II during cold acclimation rescue the impaired thermogenic capacity previously observed in PACAP deficient mice? What is the main finding and its importance? Using a genetic model of PACAP deficiency, this study provides evidence that PACAP acts upstream of the melanocortin system in regulating sympathetic nerve activity to brown adipose tissue in mice.
Abstract: Impaired adipose tissue function in obesity, including reduced thermogenic potential, has detrimental consequences for metabolic health. Hormonal regulation of adaptive thermogenesis is being explored as a potential therapeutic target for human obesity.
Lipocalin-type prostaglandin D synthase regulates light-induced phase advance of the central circadian rhythm in mice.
Commun Biol
October 2020
Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Article Synopsis
- Mice lacking the protein PACAP have reduced ability to adjust their internal clocks in response to light.* -
- Gene analysis of specific brain regions revealed that a protein called L-PGDS plays a role in their impaired response to light during late night.* -
- Mice without the DP2/CRTH2 receptor also show difficulties in advancing their internal clocks with light, suggesting that L-PGDS signals through this receptor for light-induced phase adjustment.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!